NSAIDS and Heart Disease
(Source: Mayo Clinic - Medical Edge Radio)
Source: Mayo Clinic - Medical Edge Radio - February 19, 2013 Category: Consumer Health Advice Authors: Mayo Clinic Source Type: podcasts
CKD and Heart Disease: It's a Factor -- Not a Marker
George Bakris talks to Paul Muntner via Skype about chronic kidney disease as a factor -- not a marker -- in cardiovascular disease. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - January 14, 2013 Category: Cardiology Authors: Medscape Source Type: podcasts
#54: Current state of surgical revascularization in patients with CAD with Dr Timothy Gardner
The FREEDOM trial has added a wealth of data to the debate on revascularization in patients with heart disease. Dr Timothy Gardner joins the show to discuss the revascularization options, what we have learned from FREEDOM, BARI, BARI 2D, and PREVENT ... (Source: The Bob Harrington Show)
Source: The Bob Harrington Show - January 8, 2013 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts
#54: Current state of surgical revascularization in patients with CAD with Dr Timothy Gardner
The FREEDOM trial has added a wealth of data to the debate on revascularization in patients with heart disease. Dr Timothy Gardner joins the show to discuss the revascularization options, what we have learned from FREEDOM, BARI, BARI 2D, and PREVENT ... (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - January 8, 2013 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts
#21: When congenital heart disease grows up
Thanks to important improvements in care, more than 85% of people with congenital heart disease are surviving well into adulthood. What is the best method to continue caring for these patients? (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - December 21, 2012 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
#53: Beta blockers in stable heart disease with Dr Sripal Bangalore
Despite cautious and limited guideline endorsement, beta blockers are widely used in cardiovascular disease (and beyond). Why? Our guest Dr Sripal Bangalore discusses his research, which caused a stir in CV spheres but actually does not differ greatly fro (Source: The Bob Harrington Show)
Source: The Bob Harrington Show - November 20, 2012 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts
#53: Beta blockers in stable heart disease with Dr Sripal Bangalore
Despite cautious and limited guideline endorsement, beta blockers are widely used in cardiovascular disease (and beyond). Why? Our guest Dr Sripal Bangalore discusses his research, which caused a stir in CV spheres but actually does not differ greatly fro (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - November 20, 2012 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts
#17: Treating ventricular tachycardia in patients without structural heart disease
Dr Bernard Gersh asks Dr Samuel Asirvatham about the syndromes that categorize patients who have ventricular tachycardia in the absence of structural heart disease and what the treatment options—including ablation—are for these patients. (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - October 24, 2012 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
JAMA: 2012-08-22, Vol. 308, No. 8, Author in the Room™ Audio Interview
Interview with Philip Greenland, MD, author of Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals. Summary Points:
In comparison with other competing biomarkers and risk factors, coronary artery calcium (CAC) is currently the most potent risk marker of subclinical coronary heart disease (CHD).
CAC was shown in several observational studies to improve the prediction of risk beyond traditional risk factors.
In this JAMA paper, CAC outperformed various competing risk assessment markers among asymptomatic people at intermediate risk for CHD. Whether CAC should b...
Source: JAMA Author in the Room - September 21, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA: 2012-08-22, Vol. 308, No. 8, Author in the Room ™ Audio Interview
Interview with Philip Greenland, MD, author of Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals. Summary Points:
In comparison with other competing biomarkers and risk factors, coronary artery calcium (CAC) is currently the most potent risk marker of subclinical coronary heart disease (CHD).
CAC was shown in several observational studies to improve the prediction of risk beyond traditional risk factors.
In this JAMA paper, CAC outperformed various competing risk assessment markers among asymptomatic people at intermediate risk for CHD. Whether CAC should b...
Source: JAMA Author in the Room - September 21, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
The Lancet: September 14, 2012
Mika Kivimaki discusses the relationship between stress at work and coronary heart disease. (Source: Listen to The Lancet)
Source: Listen to The Lancet - September 14, 2012 Category: General Medicine Authors: The Lancet Source Type: podcasts
